Novel anticancer drugs TLR9 agonists act by interfering with EGFR and VEGF signalling and synergize with EGFR inhibitors and with bevacizumab in wild type and cetuximab-resistant colon cancer xenografts

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Tortora, G; Caputo, R; Bianco, R; Garofalo, S; Racioppi, L; Bianco, AR; Rosa, R; Ciardiello, F; Agrawal, S; Damiano, V

Published Date

  • January 1, 2006

Published In

Volume / Issue

  • 17 /

Start / End Page

  • 137 - 137

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 30th Congress of the European-Society-for-Medical-Oncology

Conference Location

  • Istanbul, TURKEY

Conference Start Date

  • September 29, 2006

Conference End Date

  • October 3, 2006